These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 196737)

  • 1. Oat cell carcinoma of the lung: combination treatment with radiotherapy and cyclophosphamide, adriamycin, vincristine, and methotrexate.
    Wittes RE; Hopfan S; Hilaris B; Golbey RB; Melamed M; Martini N
    Cancer; 1977 Aug; 40(2):653-9. PubMed ID: 196737
    [No Abstract]   [Full Text] [Related]  

  • 2. "Total" therapy for oat cell carcinoma of the lung.
    Kent CH; Brereton HD; Johnson RE
    Int J Radiat Oncol Biol Phys; 1977; 2(5-6):427-32. PubMed ID: 195919
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunochemotherapy in 34 cases of oat cell carcinoma of the lung with 19 complete responses.
    Israël L; Depierre A; Choffel C; Milleron B; Edelstein R
    Cancer Treat Rep; 1977; 61(3):343-7. PubMed ID: 68827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination modality therapy in lung cancer: a survival study showing beneficial results of AMCOF (adriamycin, methotrexate, cyclophosphamide, oncovin and 5-fluorouracil).
    Reynolds RD; O'Dell S
    Cancer; 1978 Aug; 42(2):385-9. PubMed ID: 209881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal complications in the treatment of oat cell carcinoma with combined irradiation and chemotherapy.
    Chabora BM; Hopfan S; Wittes R
    Radiology; 1977 Apr; 123(1):185-7. PubMed ID: 191871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Prolonged survival of patients with extensive oat cell carcinoma treated with radiotherapy and cyclophosphamide (NSC-26271), vincristine (NSC-67574), and methotrexate (NSC-7040).
    Bitran J; Golomb HM; Desser RK; Colman M
    Cancer Treat Rep; 1976 Mar; 60(3):221-3. PubMed ID: 177208
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemoimmunotherapy of small cell bronchogenic carcinoma.
    Holoye PY; Samuels ML; Smith T; Sinkovics JG
    Cancer; 1978 Jul; 42(1):34-40. PubMed ID: 208755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
    Livingston RB
    Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419
    [No Abstract]   [Full Text] [Related]  

  • 9. An acceptable rate of complications in combined doxorubicin-irradiation for small cell carcinoma of the lung: A Southwest Oncology Group Study.
    Moore TN; Livingston R; Heilbrun L; Durrance FY; Tesh D; Hickman B; Bogardus C
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):675-80. PubMed ID: 213407
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung.
    Young JA; Dillman RO; Seagren SL; Taetle R; Rentschler RE; Lea JW; Lehar TJ; Green MR; Stanton W; Mendelsohn J; Royston I
    Cancer Treat Rep; 1982 Jun; 66(6):1399-401. PubMed ID: 6282459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results in combined-modality treatment of small cell carcinoma of the lung.
    Einhorn LH; Bond WH; Hornback N; Joe BT
    Semin Oncol; 1978 Sep; 5(3):309-13. PubMed ID: 211642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical research on the treatment of locally advanced lung cancer: final report of VALG Protocol 13 Limited.
    Petrovich Z; Ohanian M; Cox J
    Cancer; 1978 Sep; 42(3):1129-34. PubMed ID: 212170
    [No Abstract]   [Full Text] [Related]  

  • 13. Oat cell carcinoma of the larynx: response to combined modality therapy.
    Bitran JD; Toledo-Pereyra LH; Matz G
    Cancer; 1978 Jul; 42(1):85-7. PubMed ID: 208758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 16. Small cell lung cancer: progress and perspectives.
    Greco FA; Einhorn LH; Richardson RL; Oldham RK
    Semin Oncol; 1978 Sep; 5(3):323-35. PubMed ID: 211644
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of oat-cell carcinoma of the lung in the community.
    Citronbaum R
    Med Pediatr Oncol; 1978; 4(4):363-6. PubMed ID: 214692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of metastatic carcinoma of the breast. A 4-drug regimen.
    Mattsson W; Gynning I; Tropé C; Astedt B
    Acta Radiol Ther Phys Biol; 1977 Apr; 16(2):97-108. PubMed ID: 301341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oat cell carcinoma of the lung. Early treatment results of combination radiation therapy and chemotherapy.
    Hornback NB; Einhorn L; Shidnia H; Joe BT; Krause M; Furnas B
    Cancer; 1976 Jun; 37(6):2658-64. PubMed ID: 181121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined methotrexate and high-dose vincristine chemotherapy with radiation therapy for small cell bronchogenic carcinoma.
    Holoye PY; Libnoch JA; Anderson T; Cox JD; Byhardt RW; Hoffmann RG
    Cancer; 1985 Apr; 55(7):1436-45. PubMed ID: 2983855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.